Table 1.
Nine cases of infective endocarditis caused by Mycoplasmataceae
Patient (reference) |
Age, sex | Underlying condition(s) | Valve(s) | Symptom(s) | Diagnostic tool | Pathogen | Surgery | Antibiotic therapy (duration, weeks) | Outcome |
1 7 |
33, M | Mitral valve plasty | Mitral | Heart failure | PCR from cardiac valve | M. hominis | Y | Amo and genta (3); Doxy (4) | Survival |
2 7 |
57, F | Prosthetic aortic valve | Aortic | Heart failure | PCR from cardiac valve | U. urealyticum | Y | Vanco (8); Genta (2) | Death |
3 9 |
21, M | RHD; dental extraction without antibiotic prophylaxis 4 weeks before hospitalisation | Mitral | Fever, anorexia, sore throat, malaise | Serology | M. pneumoniae | N | Benz and genta (6); Oxy (4) | Survival |
4 10 |
25, F | SLE treated with corticosteroids; Streptococcus sanguis endocarditis; prosthetic aortic and mitral valves | Aortic and mitral | Fever | Culture from a portion of valve | M. hominis | Y | Clin and rif (6); Doxy (4) |
Survival |
5 11 |
40, M | RHD, aortic and mitral replacement | Aortic and mitral | Abdominal pain, jaundice, fever | 16S rDNA PCR, culture | M. hominis | Y | Doxy and clin (8) | Survival |
6 12 |
74, M | Aortic and mitral valve replacement | Aortic | Dizziness, cardiac and kidney failure | 16S rDNA PCR, culture | M. hominis | Y | Doxy and clin (9) | Survival |
7 13 |
57, M | Aortic valve replacement, aortic root and mitral repair | Aortic | Dyspnoea, fatigue, chest pain | 16S rDNA PCR | M. hominis | Y | Doxy and clin (9) | Survival |
8 8 |
46, M | Mitral valve replacement | Mitral | Dyspnoea, heart failure | Culture | M. hominis | Y | Vanco and amika | Death |
9 (PR) |
56, M | s/p lymphoma, s/p septic arthritis with U. parvum | Aortic | Dyspnoea, heart failure | PCR from cardiac valve | U. parvum | Y | Doxy (8) | Survival (15 months after surgery) |
Amika, amikacin, Amo, amoxicillin, Benz, benzylpenicillin, Clin, clindamycin, Doxy, doxycycline, Genta, gentamicin, Oxy, oxytetracycline, PR, present report, RHD, rheumatic heart disease, Rif, rifampin, SLE, systemic lupus erythematosus, s/p, status post, Vanco, vancomycin